首页 >
法规速递
-
Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research Guidance for Industry(Final)-2023/01/23
2023-01-23查看详情 > -
Mpox: Development of Drugs and Biological Products; Guidance for Industry(Draft)-2023/01/19
2023-01-19查看详情 > -
Dosage and Administration Section of Labeling for Human Prescription Drug and Biological Products — Content and Format(Draft)-2023/01/12
2023-01-12查看详情 > -
Format and Content of a REMS Document Guidance for Industry(Final)-2023/01/04
2023-01-04查看详情 > -
Controlled Correspondence Related to Generic Drug Development (Draft)-2022/12/21
2022-12-22查看详情 > -
M11 Clinical Electronic Structured Harmonised Protocol (Draft)-2022/12/21
2022-12-22查看详情 > -
M11 Technical Specification: Clinical Electronic Structured Harmonised Protocol (Draft)-2022/12/21
2022-12-22查看详情 > -
M11 Template: Clinical Electronic Structured Harmonised Protocol (Draft)-2022/12/21
2022-12-22查看详情 > -
Hypertension Indication: Drug Labeling for Cardiovascular Outcome Claims (Final)-2022/12/15
2022-12-16查看详情 > -
Guidance: Pulmonary Tuberculosis: Developing Drugs for Treatment (Draft)-2022/12/14
2022-12-15查看详情 >
